State of Wyoming’s Vigil Neuroscience VIGL Stock Holding History

State of Wyoming’s Portfolio VIGL Stock Details VIGL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-143	Closed	-$1.34K	–	1831
2023 Q2	$1.34K	Buy	143 +42	+42%	+$397	﹤0.01%	1510
2023 Q1	$989	Sell	101 -3	-3%	-$34	﹤0.01%	1537
2022 Q4	$1.3K	Buy	104 +58	+126%	+$712	﹤0.01%	1510
2022 Q3	$0	Buy	+46	New	+$337	﹤0.01%	1962

Other funds holding VIGL

AVLSA

Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return

Northpond Ventures Bethesda, Maryland $43.7M AUM 27.27% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CAM

Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

State of Wyoming's VIGL Position: Q3 2023 in Review

State of Wyoming sold out of Vigil Neuroscience (VIGL) in Q3 2023, closing a stake of 143 shares — an estimated $1.34K sold.

State of Wyoming first reported a position in VIGL in Q3 2022 and held it in 4 quarters. The position peaked at $1.34K in Q2 2023. 45 funds tracked by Wall St. Rank hold VIGL as of Q3 2023.

State of Wyoming reported no remaining Vigil Neuroscience position as of Q3 2023 after selling out during the quarter.
State of Wyoming sold 143 Vigil Neuroscience shares in Q3 2023, an estimated $1.34K.
State of Wyoming first reported a position in Vigil Neuroscience in Q3 2022 and held it in 4 quarters.
State of Wyoming's Vigil Neuroscience position peaked at $1.34K in Q2 2023.
45 funds tracked by Wall St. Rank held Vigil Neuroscience as of Q3 2023.

Based on State of Wyoming's 13F filing for Q3 2023, filed 14 Nov 2023.